Rural Area Pharmacist Intervention for Diabetes

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

October 12, 2024

Study Completion Date

March 26, 2025

Conditions
Type 2 Diabetes
Interventions
OTHER

telehealth-based clinical pharmacy intervention

The pharmacist will perform an initial comprehensive review of the medication regimen, make any adjustments, document those in the patient's electronic health record (EHR) and communicate with the patient's T2D care team as needed. They will also call (using an EHR-based software) the patient using phone/video to educate them about T2D self-management and identify any medication-related unmet needs. Periodic reviews of the medication regimen and roughly biweekly follow-up patient calls will occur with frequency based on need (as judged by the pharmacist). Patient intervention calls will be personalized depending on HbA1c levels, comorbidities, and medication complexity

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

lead

Wake Forest University Health Sciences

OTHER

NCT05761886 - Rural Area Pharmacist Intervention for Diabetes | Biotech Hunter | Biotech Hunter